Please login to the form below

Not currently logged in
Email:
Password:

Pomalyst

This page shows the latest Pomalyst news and features for those working in and with pharma, biotech and healthcare.

FDA green lights BMS’ multiple myeloma combo

FDA green lights BMS’ multiple myeloma combo

This comprises another Celgene product Pomalyst, along with dexamethasone, and has delivered some robust results. ... The results showed the combination could cut the risk of myeloma progression by 46% compared to Pomalyst and dexamethasone alone (Pd)

Latest news

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics